Haynes, Richard http://orcid.org/0000-0002-1179-0023
,
Chen, Fang
Wincott, Elizabeth
Dayanandan, Rejive
Lay, Michael J.
Parish, Sarah
Bowman, Louise
Landray, Martin J.
Armitage, Jane
Funding for this research was provided by:
Merck (n/a)
Medical Research Council (n/a)
Article History
Received: 14 January 2019
Accepted: 9 October 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: The HPS2-THRIVE trial (and the studies described above) were reviewed and approved by the Berkshire Research Ethics Committee (reference 06/MRE12/043). As these trials involved different invitation processes, participants were not asked to provide consent.
: Not applicable.
: The authors declare that they have no competing interests.